Current status of the preclinical evaluation of alternating electric fields as a form of cancer therapy

Tumor Treating Fields (TTFields) Reversibly Permeabilize the Blood-Brain Barrier In Vitro and In Vivo

First multicentric real-life experience with the combination of CCNU and temozolomide in newly diagnosed MGMT promoter methylated IDH wildtype glioblastoma

Determinants of tumor treating field usage in patients with primary glioblastoma: A single institutional experience

Tumor Treating Fields (TTFields) therapy vs physicians' choice standard-of-care treatment in patients with recurrent glioblastoma: a post-approval registry study (EF-19)

Tumor Treating Fields Combine with Temozolomide for Newly Diagnosed Glioblastoma: A Retrospective Analysis of Chinese Patients in a Single Center

Glioblastoma - treatment and obstacles

Current therapeutic options for glioblastoma and future perspectives

A narrative review on the management of glioblastoma in China

Safety of Tumor Treating Fields (TTFields) therapy in pediatric patients with malignant brain tumors: Post-marketing surveillance data

Current and promising treatment strategies in glioma

Management of dermatologic adverse events associated with tumor treating fields in patients with glioblastoma multiforme: A 27-case series

Dexamethasone and compliance affect TTFields efficacy to glioblastoma patients: a systematic review and meta-analysis

Anti-cancer mechanisms of action of therapeutic alternating electric fields (tumor treating fields [TTFields])

Tumor-Treating Fields in Glioblastomas: Past, Present, and Future

Characteristics and trends of globally registered glioma clinical trials in the past 16 years

Tumor treating fields affect mesothelioma cell proliferation by exerting histotype-dependent cell cycle checkpoint activations and transcriptional modulations

The mechanisms of action of Tumor Treating Fields

Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating Fields

The Routine Application of Tumor-Treating Fields in the Treatment of Glioblastoma WHO° IV

Guidelines for Burr Hole Surgery in Combination With Tumor Treating Fields for Glioblastoma: A Computational Study on Dose Optimization and Array Layout Planning

Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo

Comparative efficacy and safety of therapeutics for elderly glioblastoma patients: A Bayesian network analysis

The safety profile of Tumor Treating Fields (TTFields) therapy in glioblastoma patients with ventriculoperitoneal shunts.

Scalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed Glioblastoma

Feasibility of Tumor Treating Fields with Pemetrexed and Platinum-Based Chemotherapy for Unresectable Malignant Pleural Mesothelioma: Single-Center, Real-World Data

First Report of Tumor Treating Fields (TTFields) Therapy for Glioblastoma in Comorbidity with Multiple Sclerosis

Signaling pathways and therapeutic approaches in glioblastoma multiforme (Review)

Efficacy and safety of tumor-treating fields in recurrent glioblastoma: a systematic review and meta-analysis

Recent Advances in the Therapeutic Strategies of Glioblastoma Multiforme

Protocol for live-cell imaging during Tumor Treating Fields treatment with Inovitro Live

Case report: Awake craniotomy during pregnancy for resection of glioblastoma

Tumor Treating Fields Suppression of Ciliogenesis Enhances Temozolomide Toxicity

Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study

Effectiveness of different treatment strategies in elderly patients with glioblastoma: An evidence map of randomized controlled trials

Genome-Wide Expression and Anti-Proliferative Effects of Electric Field Therapy on Pediatric and Adult Brain Tumors

PARP Inhibitors in Glioma: A Review of Therapeutic Opportunities

Tumor Treating Fields dually activate STING and AIM2 inflammasomes to induce adjuvant immunity in glioblastoma

Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of cytotoxic chemotherapy and other cytotoxic therapies in the management of progressive glioblastoma in adults

Newly Diagnosed Glioblastoma in Elderly Patients

Clinical strategies to manage adult glioblastoma patients without MGMT hypermethylation

The Impact of Tumor Treating Fields on Glioblastoma Progression Patterns

Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline

Tumor treating fields: An emerging treatment modality for thoracic and abdominal cavity cancers

An overview on tumor treating fields (TTFields) technology as a new potential subsidiary biophysical treatment for COVID-19

DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies

Computational simulations establish a novel transducer array placement arrangement that extends delivery of therapeutic TTFields to the infratentorium of patients with brainstem gliomas

Health-Related Quality of Life for Patients Receiving Tumor Treating Fields for Glioblastoma

Tumor-Treating Fields: A fourth modality in cancer treatment, new practice updates

Glioma invasion along white matter tracts: A dilemma for neurosurgeons

Establishment of Tumor Treating Fields Combined With Mild Hyperthermia as Novel Supporting Therapy for Pancreatic Cancer.

Study protocol for OptimalTTF-2: enhancing Tumor Treating Fields with skull remodeling surgery for first recurrence glioblastoma: a phase 2, multi-center, randomized, prospective, interventional trial

Tumor Treating Fields (TTFields) downregulate the Fanconi Anemia-BRCA pathway and increase the efficacy of chemotherapy in malignant pleural mesothelioma preclinical models

An insight into the risk factors of brain tumors and their therapeutic interventions

Tumor Treating Fields for Ovarian Carcinoma: A Modeling Study

Tumor treating fields combined with a poly (adenosine diphosphate-ribose) polymerase inhibitor during radiotherapy for rapidly progressing IDH-wildtype diffuse astrocytoma: a case report

Dexamethasone Treatment Limits Efficacy of Radiation, but Does Not Interfere With Glioma Cell Death Induced by Tumor Treating Fields

Case Report: End-Stage Recurrent Glioblastoma Treated With a New Noninvasive Non-Contact Oncomagnetic Device

Dielectrophoresis Structurization of PZT/PDMS Micro-Composite for Elastronic Function: Towards Dielectric and Piezoelectric Enhancement

Tumor-Treating Fields for the treatment of glioblastoma: a systematic review and meta-analysis

Therapy of pancreatic cancer with alternating electric fields: Limitations of the method

T Cells Retain Pivotal Antitumoral Functions under Tumor-Treating Electric Fields

Progress and prospect in tumor treating fields treatment of glioblastoma

Thymidine decreases the DNA damage and apoptosis caused by tumor-treating fields in cancer cell lines

Tumor-treating fields (TTFields)-based cocktail therapy: a novel blueprint for glioblastoma treatment

Tumor-Treating Fields Therapy for Pediatric Brain Tumors

Brain-invasive meningiomas: molecular mechanisms and potential therapeutic options

PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma

Observations on the anti-glioma potential of electrical fields: is there a role for surgical neuromodulation?

Advances in radiotherapy and comprehensive treatment of high-grade glioma: immunotherapy and tumor-treating fields

Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF-phase I/II trial

Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [ 18 F]DASA-23, a non-invasive probe of pyruvate kinase M2 (PKM2) expression

Tumour treating fields therapy for glioblastoma: current advances and future directions

Rapalink-1 Targets Glioblastoma Stem Cells and Acts Synergistically with Tumor Treating Fields to Reduce Resistance against Temozolomide

Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma

Feasibility of Treating High Grade Gliomas in Children with Tumor-Treating Fields: A Case Series

Sorafenib increases tumor treating fields-induced cell death in glioblastoma by inhibiting STAT3

An overview of potential novel mechanisms of action underlying Tumor Treating Fields-induced cancer cell death and their clinical implications

Tumor Treating Fields (TTFields) Hinder Cancer Cell Motility through Regulation of Microtubule and Acting Dynamics

Tumor treating fields (TTF) treatment enhances radiation-induced apoptosis in pancreatic cancer cells

Optimal treatment strategy for adult patients with newly diagnosed glioblastoma: a systematic review and network meta-analysis

Clinical Efficacy of Tumor Treating Fields for Newly Diagnosed Glioblastoma

Tumor-Treating Fields at EMBC 2019: A Roadmap to Developing a Framework for TTFields Dosimetry and Treatment Planning

Improving Tumor-Treating Fields with Skull Remodeling Surgery, Surgery Planning, and Treatment Evaluation with Finite Element Methods

A Thermal Study of Tumor-Treating Fields for Glioblastoma Therapy

How Do Tumor-Treating Fields Work?

Physical approaches to treat glioblastoma

Heat transfer during TTFields treatment: Influence of the uncertainty of the electric and thermal parameters on the predicted temperature distribution

Evaluation of a tumor electric field treatment system in a rat model of glioma

Tumor Treating Fields in the Management of Patients with Malignant Gliomas

Gene expression profiling of glioblastoma cell lines depending on TP53 status after tumor-treating fields (TTFields) treatment

Tumor Treating Fields - Behind and Beyond Inhibiting the Cancer Cell Cycle

A systematic review of tumor treating fields therapy for high-grade gliomas

Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice

A Theoretical Analysis of the Effects of Tumor-Treating Electric Fields on Single Cells

Tumor treating fields for high-grade gliomas

The Value of Tumor Treating Fields in Glioblastoma

Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial

Impact of Peritumoral Edema During Tumor Treatment Field Therapy: A Computational Modelling Study

Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma

Tumor treating fields in neuro-oncology: integration of alternating electric fields therapy into promising treatment strategies

Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy

Barium Titanate Nanoparticles Sensitise Treatment-Resistant Breast Cancer Cells to the Antitumor Action of Tumour-Treating Fields

Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial

Finite element analysis of Tumor Treating Fields in a patient with posterior fossa glioblastoma

A Theoretical Study on the Biophysical Mechanisms by Which Tumor Treating Fields Affect Tumor Cells During Mitosis

Complete radiological response following subtotal resection in three glioblastoma patients under treatment with Tumor Treating Fields

Tumor treating fields cause replication stress and interfere with DNA replication fork maintenance: Implications for cancer therapy